In a landmark development set to transform healthcare access across India, Bhubaneswar-based startup EzeRx has signed a strategic Memorandum of Understanding (MoU) with biotechnology company IMGENEX India. This collaboration brings together two healthcare innovators to advance a shared mission: making quality medical care affordable and accessible to all Indians.
Leveraging EzeRx's expertise in artificial intelligence (AI)-powered medical devices and IMGENEX's leadership in cutting-edge biotechnology, the partners aim to develop cutting-edge screening and diagnostic solutions that are indigenous, low-cost, and effective. This first-of-its-kind partnership unites technical prowess with purpose, applying technology to bridge gaps in preventive care and early diagnosis.
EzeRx has previously partnered with leading companies like TCS, Infosys Foundation, and Indian Oil Corporation. However, this strategic partnership with IMGENEX holds special significance for advancing indigenous manufacturing and R&D in healthcare.
The MoU outlines joint initiatives to provide low-cost, effective, and privacy-protected screening solutions, particularly for diseases affecting women. This purpose-driven partnership aims to transform healthcare access across India and also explore global opportunities. Together, EzeRx and IMGENEX aim to develop India-centric solutions that set a benchmark in quality, cost-effectiveness, and scalability.
